HAEMONETICS CORPORATION
Last · NYSE$121.11-0.61 (-0.50%)close · yahoo · 7h ago
Vol 581.8K ≈ 70.46M
MA10MA20MA50
Market cap$5.51B45.5M sh
P/E · TTM58.5fwd 21.0 · eps 2.07
Beta0.61vs S&P 500
Div yield0.00%annual · TTM
52w range
$48.55$123.77
Volume581.8Ksession
Issuer
Legal nameHAEMONETICS CORPORATION
HQUnited States (US)
ListingUS HAE
ISINUS4050241003
SectorHealthcare
IndustryHealthcare Products
SIC3841
CurrencyUSD
Entity registrysec:0000313143
CIK0000313143
Websitehaemonetics.gcs-web.com
Employees3,009
AddressHaemonetics Corp. 125 Summer Street 02110, Boston +781 848 7100
| Revenue | $1.4B |
|---|---|
| Operating income | $57.5M |
| Net income | $33.0M |
| Free cash flow | $44.4M |
| Operating margin | 4.2% |
| Net margin | 2.4% |
| Return on equity | 3.9% |
| Period | TTM 2026-06-27 |
Loading chart…
Upcoming earnings
THU.5NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$1.29
Est. revenue
345.1M
Earnings transcripts
Documents
FormReporting forFiledFlags
Showing 5 of 38 filings